Q4 2019 Lineage Cell Therapeutics Inc Earnings Call
שיחת ועידה Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc Conference call will be held on 12/03/2020. During the earnings conference call's session Lineage Cell Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Lineage Cell Therapeutics Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from two of our core technology platforms. We believe we have the world's premier collection of pluripotent stem cell assets and the best cell delivery platform. The foundation of our core therapeutic technology platform is pluripotent stem cells that are capable of becoming any of the cell types in the human body. Cell types derived from pluripotent stem cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures.קרא עוד שיחת ועידה